Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Cognitive tests and assessment

Topic: Risk, prevention and care in population studies

Plain-language summary

The mean hippocampal volumes were significantly smaller in the DEM group compared to the MCI and healthy groups (P <0.0001). Right hippocampal volumes were 1.69 ± 0.47 cm³ in the DEM group, 2.12 ± 0.23 cm³ in MCI, and 2.64 ± 0.33 cm³ in healthy participants. A progressive hippocampal volume loss of 34.7% from MCI to DEM was observed. Significant differences in MMSE scores were found between groups (P < 0.005). A strong positive correlation between MMSE scores and hippocampal volumes was noted in the DEM group (r = 0.55, P <0.05). The findings confirm that hippocampal atrophy is a key feature of cognitive decline, with substantial volume loss observed in dementia patients compared to MCI and healthy individuals. The strong correlation between hippocampal volume and cognitive performance in dementia underscores the role of hippocampal measurements as potential diagnostic and monitoring biomarkers.

What this study adds

Evidence grade: Low

The record lists 22 participants. People with dementia had significantly smaller hippocampal volumes than those with mild cognitive impairment or healthy participants, and smaller volume went with worse cognitive scores. Reported effect size: 34.7%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Bashir, S., Hassan, M. G., Mir, M. F., & Majeed, H. A. (2025). Hippocampal Volume Loss as A Marker of Cognitive Decline in Dementia and Mild Cognitive Impairment: A Comprehensive Prospective Study. National Journal of Medical Research. https://doi.org/10.55489/njmr.150220251079

Vancouver

Bashir S, Hassan MG, Mir MF, Majeed HA. Hippocampal Volume Loss as A Marker of Cognitive Decline in Dementia and Mild Cognitive Impairment: A Comprehensive Prospective Study. National Journal of Medical Research. 2025. doi:10.55489/njmr.150220251079.

BibTeX

@article{bashir2025-3b487336,
  author  = {Bashir, Shazia and Hassan, Mir G. and Mir, Mohammad Farooq and Majeed, H. A.},
  title   = {{Hippocampal Volume Loss as A Marker of Cognitive Decline in Dementia and Mild Cognitive Impairment: A Comprehensive Prospective Study}},
  journal = {National Journal of Medical Research},
  year    = {2025},
  doi     = {10.55489/njmr.150220251079},
  url     = {https://doi.org/10.55489/njmr.150220251079}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

People with dementia had significantly smaller hippocampal volumes than those with mild cognitive impairment or healthy participants, and smaller volume went with worse cognitive scores. This supports hippocampal measurement as a possible marker for diagnosis and monitoring, but it does not treat or prevent dementia.

Study details

How this study scored 38/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 1 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 36 of the 96 points it could be judged on, which is 38 of 100. Total 38 of 100.36 of the 96 points we could judge = 38 of 100

Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 36 of the 96 points we could judge it on, which is 38 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (National Journal of Medical Research)
Journal's citation record 0 / 4 National Journal of Medical Research: journal h-index 22 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 1 / 4 22 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record 0 / 3 Sher-i-Kashmir Institute of Medical Sciences: institution h-index 152 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 36 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 36 of the 96 points we could judge it on is 38 out of 100.
Total 38 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Cognitive tests and assessment from nearby years

Also tagged “disorder”

492 studies in the library carry the topic tag “disorder”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 492 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Cognitive tests and assessment

See all studies in Cognitive tests and assessment →